ArticleAnnals of hematology2022

A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes.

Mikkael A Sekeres et al.PubMed ↗Publisher ↗

No numbers read from the abstract.